Crooks Benjamin, Harrison Simon, Millward Graham, Hall Kirsty, Taylor Michael, Farrer Kirstine, Abraham Arun, Teubner Antje, Lal Simon
Intestinal Failure Unit, Salford Royal NHS Foundation Trust, Salford, UK.
Division of Diabetes, Endocrinology, and Gastroenterology, School of Medical Sciences, The University of Manchester and Manchester Academic Health Sciences Centre, Manchester, UK.
JPEN J Parenter Enteral Nutr. 2022 Jan;46(1):254-257. doi: 10.1002/jpen.2225. Epub 2021 Aug 6.
The risk of bloodstream infections may be increased in hospitalized patients receiving ready-made parenteral nutrition (PN) multichamber bags (MCBs) compared with customized PN; however, as highlighted in recent international guidelines, there are no comparable data relating to home PN (HPN).
Data from a prospectively maintained database were analyzed to compare incidence rates of catheter-related bloodstream infections (CRBSIs) between patients receiving customized HPN compared with MCB HPN at a national UK referral center between May 2018 and August 2020.
Sixty patients with chronic intestinal failure were commenced on MCBs and 45 received customized HPN for a total of 5914 and 7641 catheter days, respectively. No difference in CRBSI incidence was found (0.51/1000 catheter days for MCBs, 0.39/1000 catheter days for customized HPN; incidence rate ratio, 1.29; 95% CI, 0.26-6.37). Eighteen patients were switched from customized HPN to MCB HPN. The study period covered 7401 catheter days receiving customized HPN and 4834 days on MCBs. No significant change was noted in the CRBSI rates following this switch (0.27/1000 catheter days receiving customized HPN vs 0.21/1000 catheter days on MCBs; incidence rate ratio, 1.31; 95% CI, 0.12-14.3).
The use of MCBs for HPN patients is not associated with an increased risk of CRBSI. This study will inform international guidelines and provide reassurance for the continued, safe use of MCB HPN.
与定制肠外营养(PN)相比,接受即用型肠外营养多腔袋(MCB)的住院患者发生血流感染的风险可能会增加;然而,正如最近国际指南所强调的,目前尚无关于家庭肠外营养(HPN)的可比数据。
分析前瞻性维护数据库中的数据,以比较2018年5月至2020年8月期间,在英国一家全国转诊中心接受定制HPN与MCB HPN的患者之间导管相关血流感染(CRBSI)的发生率。
60例慢性肠衰竭患者开始使用MCB,45例接受定制HPN,导管使用天数分别为5914天和7641天。未发现CRBSI发生率有差异(MCB为0.51/1000导管日,定制HPN为0.39/1000导管日;发生率比为1.29;95%CI为0.26 - 6.37)。18例患者从定制HPN转换为MCB HPN。研究期间,接受定制HPN的导管使用天数为7401天,使用MCB的天数为4834天。转换后CRBSI发生率无显著变化(接受定制HPN时为0.27/1000导管日,使用MCB时为0.21/1000导管日;发生率比为1.31;95%CI为0.12 - 14.3)。
HPN患者使用MCB与CRBSI风险增加无关。本研究将为国际指南提供参考,并为MCB HPN的持续安全使用提供保障。